EPIX buys back $3.12 million of 3% convertible senior notes due 2024

By Devika Patel

Knoxville, Tenn., July 10 - EPIX Pharmaceuticals, Inc. bought back $2.9 million of its 3% convertible senior notes due 2024 from Citigroup Global Markets Inc. on July 9, according to an 8-K filed Friday with the Securities and Exchange Commission. It also bought back $215,000 of the 3% convertibles from Loomis, Sayles & Co., LP on the same day.

The Citigroup notes were repurchased for $521,280 in cash and 3,644,352 common shares. The Loomis notes were repurchased for $74,413.65 in cash.

Following these repurchases, $50,000 of the convertibles remain outstanding.

Lexington, Mass.-based EPIX is a biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.